Global In Vitro Diagnostics (IVD) Market -Global Industry Analysis and Forecast (2018-2026)- by Product Segment, Technology , End User, Geography.

Global In Vitro Diagnostics (IVD) Market -Global Industry Analysis and Forecast (2018-2026)- by Product Segment, Technology , End User, Geography.

Market Scenario

Global in Vitro Diagnostics IVD Market was valued US$ 63 Bn in 2017 and is expected to reach US$ 111.07 Bn by 2026 at CAGR of 7.35 %.( Detailed analysis of the market CAGR is provided in the report) In Vitro Diagnostics (IVD) Market Global in Vitro Diagnostics IVD Market Global In-Vitro Diagnostics market is segmented into product segment, application, technology, end-user, geography. On the basis of product segment market is segmented into Reagents and Consumables, Instruments and Systems, according to an application, a market is divided into Diabetes, Infectious Diseases, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/Pharma genomics, HIV/AIDS. Based on the technology market is classified into Immunochemistry, Clinical chemistry, Hematology, Infectious Immunology, Microbiology Culture, Genetic Testing, Histology, and Cytology. According to end-user market is divided into Hospitals, Laboratories, Point-Of-Care Testing Hematology, Patient Self-Testing, Academic Institutes, and Other End-Users. Geographically market is spread by North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. The increasing prevalence of lifestyle and chronic diseases, a growing acceptance of molecular diagnostics in personalized medicine, growth in the number of private diagnostic and caring centers is expected to fuel the market during the analysis period. Additionally, a rise in investment for the development of the healthcare sector by a government is anticipated to boost the market growth. Recent R&D activities related to IVD are likely to present new opportunities for the market. However, firm rules and regulations for the production of IVD products, lack of reimbursement and increasing healthcare cost are expected to restrain the market growth. The Growing Product segment is instruments and systems growing at a CAGR ranging from 5.5 to 7 during the forecast period. Asia-Pacific is estimated to be the fastest-growing geographic region, growing at a CAGR ranging from 6% to 8.5% by 2026 In-Vitro Diagnostics (IVD) is a method of diagnostic, used to detect any kind of infection and diseases by taking the specimen from the human body to cure diseases. The market segment ranges from hospitals and clinics to that in research centers. In 2017, North America is predictable to dominate the market followed by Europe. The market in North America is primarily driven by the implementation of fully automated instruments, availability of government funds, increasing use of molecular diagnostics in genetic disorders and cancer screening, and the presence of key players in the US key players operated in the market are Danaher Corporation, Carlyle Investment Management L.L.C., Siemens AG, Becton, Dickinson, and Company, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, BioMérieux SA, Abbott, Johnson & Johnson (US), Roche Diagnostics (Switzerland),Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), Agilent Technologies (US), and QIAGEN (Germany).

Scope of Global In Vitro Diagnostics IVD Market

Global In-Vitro Diagnostics (IVD) Market, By Product

• Reagents & Kits • Instruments o Fully-automated Instruments o Semi-automated Instruments o Others • Data Management Software • Services

Global In-Vitro Diagnostics (IVD) Market, By Application

• Diabetes • Infectious Diseases • Oncology/Cancer • Cardiology • Nephrology • Autoimmune Diseases • Drug Testing/Pharmacogenomics • HIV/AIDS • Others

Global In-Vitro Diagnostics (IVD) Market, By Technology

• Immunochemistry o Enzyme-Linked Immunosorbent Assay (ELISA) o Radioimmunoassays (RIA) o Rapid Tests o Western Blot o ELISPOT • Clinical chemistry o Basic Metabolic Panel o Electrolyte Panel o Liver Panel o Lipid Profile o Renal Profile o Thyroid Function Panel o Specialty Chemicals • Molecular Diagnostics o Polymerase Chain Reaction (PCR) o Isothermal Nucleic Acid Amplification Technology (INAAT) o Hybridization (In-situ Hybridization & FISH) o DNA Sequencing & NGS o Microarray o Others • Microbiology • Hematology • Coagulation & Hemostasis • Urinalysis • Others

Global In-Vitro Diagnostics (IVD) Market, By End User

• Laboratories o Large/Reference Laboratories o Small & Medium-sized Laboratories • Hospitals • Academics • Point-Of-Care Testing • Patient Self-Testing • Others

Key Players

• Danaher Corporation • Carlyle Investment Management L.L.C. • Siemens AG • Becton, Dickinson, and Company • Thermo Fisher Scientific Inc. • F. Hoffmann-La Roche Ltd • BioMérieux SA • Abbott • Johnson & Johnson • Roche Diagnostics • Bio-Rad Laboratories • Sysmex Corporation • BioMérieux • DiaSorin • Ortho Clinical Diagnostics • Agilent Technologies • QIAGEN Molecular Diagnostics Market 

Table of Contents

Global In-Vitro Diagnostics Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global In-Vitro Diagnostics (IVD) Market Size, by Market Value (US$ Bn ) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast 6.1. Global In-Vitro Diagnostics (IVD) Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Product 7.4. Global In-Vitro Diagnostics (IVD) Market Size (US$ Bn ) Forecast, by Product 7.5. Global In-Vitro Diagnostics (IVD) Market Analysis, by Product 7.6. Global In-Vitro Diagnostics (IVD) Market Attractiveness Analysis, by Product 8. Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast, by 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global In-Vitro Diagnostics (IVD) Market Value Share Analysis, by End User 8.4. Global In-Vitro Diagnostics (IVD) Market Size (US$ Bn ) Forecast, by End User 8.5. Global In-Vitro Diagnostics (IVD) Market Analysis, by End User 8.6. Global In-Vitro Diagnostics (IVD) Market Attractiveness Analysis, by End User 9. Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast, by Technology 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Technology 9.4. Global In-Vitro Diagnostics (IVD) Market Size (US$ Bn ) Forecast, by Technology 9.5. Global In-Vitro Diagnostics (IVD) Market Analysis, by Technology 9.6. Global In-Vitro Diagnostics (IVD) Market Attractiveness Analysis, by Technology 10. Global In-Vitro Diagnostics (IVD) Market Analysis and Forecast, by Application 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Application 10.4. Global In-Vitro Diagnostics (IVD) Market Size (US$ Bn ) Forecast, by Application 10.5. Global In-Vitro Diagnostics (IVD) Market Analysis, by Application 10.6. Global In-Vitro Diagnostics (IVD) Market Attractiveness Analysis, by Application 11. Global In-Vitro Diagnostics (IVD) Market Analysis, by Region 11.1. Global In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Region 11.2. Global In-Vitro Diagnostics (IVD) Market Size (US$ Bn ) Forecast, by Region 11.3. Global In-Vitro Diagnostics (IVD) Market Attractiveness Analysis, by Region 12. North America In-Vitro Diagnostics (IVD) Market Analysis 12.1. Key Findings 12.2. North America In-Vitro Diagnostics (IVD) Market Overview 12.3. North America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Product 12.4. North America In-Vitro Diagnostics (IVD) Market Forecast, by Product 12.4.1. Reagents & Kits 12.4.2. Instruments 12.4.2.1. Fully-automated Instruments 12.4.2.2. Semi-automated Instruments 12.4.2.3. Others 12.4.3. Data Management Software 12.4.4. Services 12.5. North America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by End User 12.6. North America In-Vitro Diagnostics (IVD) Market Forecast, by End User 12.6.1. Laboratories 12.6.1.1. Large/Reference Laboratories 12.6.1.2. Small & Medium-sized Laboratories 12.6.2. Hospitals 12.6.3. Academics 12.6.4. Point-Of-Care Testing 12.6.5. Patient Self-Testing 12.6.6. Others 12.7. North America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Technology 12.8. North America In-Vitro Diagnostics (IVD) Market Forecast, by Technology 12.8.1. Immunochemistry 12.8.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 12.8.1.2. Radioimmunoassays (RIA) 12.8.1.3. Rapid Tests 12.8.1.4. Western Blot 12.8.1.5. ELISPOT 12.8.2. Clinical chemistry 12.8.2.1. Basic Metabolic Panel 12.8.2.2. Electrolyte Panel 12.8.2.3. Liver Panel 12.8.2.4. Lipid Profile 12.8.2.5. Renal Profile 12.8.2.6. Thyroid Function Panel 12.8.2.7. Specialty Chemicals 12.8.3. Molecular Diagnostics 12.8.3.1. Polymerase Chain Reaction (PCR) 12.8.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.8.3.3. Hybridization (In-situ Hybridization & FISH) 12.8.3.4. DNA Sequencing & NGS 12.8.3.5. Microarray 12.8.3.6. Others 12.8.4. Microbiology 12.8.5. Hematology 12.8.6. Coagulation & Hemostasis 12.8.7. Urinalysis 12.8.8. Others 12.9. North America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Application 12.10. North America In-Vitro Diagnostics (IVD) Market Forecast, by Application 12.10.1. Food Processing 12.10.2. Dressing and Sauces 12.10.3. Ready Meals 12.10.4. Snacks & Savory Products 12.10.5. Infant Foods 12.10.6. Soups 12.10.7. Others 12.11. North America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Country 12.12. North America In-Vitro Diagnostics (IVD) Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America In-Vitro Diagnostics (IVD) Market Analysis, by Country 12.14. U.S. In-Vitro Diagnostics (IVD) Market Forecast, by Product 12.14.1. Reagents & Kits 12.14.2. Instruments 12.14.2.1. Fully-automated Instruments 12.14.2.2. Semi-automated Instruments 12.14.2.3. Others 12.14.3. Data Management Software 12.14.4. Services 12.15. U.S. In-Vitro Diagnostics (IVD) Market Forecast, by End User 12.15.1. Laboratories 12.15.1.1. Large/Reference Laboratories 12.15.1.2. Small & Medium-sized Laboratories 12.15.2. Hospitals 12.15.3. Academics 12.15.4. Point-Of-Care Testing 12.15.5. Patient Self-Testing 12.15.6. Others 12.16. U.S. In-Vitro Diagnostics (IVD) Market Forecast, by Technology 12.16.1. Immunochemistry 12.16.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 12.16.1.2. Radioimmunoassays (RIA) 12.16.1.3. Rapid Tests 12.16.1.4. Western Blot 12.16.1.5. ELISPOT 12.16.2. Clinical chemistry 12.16.2.1. Basic Metabolic Panel 12.16.2.2. Electrolyte Panel 12.16.2.3. Liver Panel 12.16.2.4. Lipid Profile 12.16.2.5. Renal Profile 12.16.2.6. Thyroid Function Panel 12.16.2.7. Specialty Chemicals 12.16.3. Molecular Diagnostics 12.16.3.1. Polymerase Chain Reaction (PCR) 12.16.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.16.3.3. Hybridization (In-situ Hybridization & FISH) 12.16.3.4. DNA Sequencing & NGS 12.16.3.5. Microarray 12.16.3.6. Others 12.16.4. Microbiology 12.16.5. Hematology 12.16.6. Coagulation & Hemostasis 12.16.7. Urinalysis 12.16.8. Others 12.17. U.S. In-Vitro Diagnostics (IVD) Market Forecast, by Application 12.17.1. Food Processing 12.17.2. Dressing and Sauces 12.17.3. Ready Meals 12.17.4. Snacks & Savory Products 12.17.5. Infant Foods 12.17.6. Soups 12.17.7. Others 12.18. Canada In-Vitro Diagnostics (IVD) Market Forecast, by Product 12.18.1. Reagents & Kits 12.18.2. Instruments 12.18.2.1. Fully-automated Instruments 12.18.2.2. Semi-automated Instruments 12.18.2.3. Others 12.18.3. Data Management Software 12.18.4. Services 12.19. Canada In-Vitro Diagnostics (IVD) Market Forecast, by End User 12.19.1. Laboratories 12.19.1.1. Large/Reference Laboratories 12.19.1.2. Small & Medium-sized Laboratories 12.19.2. Hospitals 12.19.3. Academics 12.19.4. Point-Of-Care Testing 12.19.5. Patient Self-Testing 12.19.6. Others 12.20. Canada In-Vitro Diagnostics (IVD) Market Forecast, by Technology 12.20.1. Immunochemistry 12.20.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 12.20.1.2. Radioimmunoassays (RIA) 12.20.1.3. Rapid Tests 12.20.1.4. Western Blot 12.20.1.5. ELISPOT 12.20.2. Clinical chemistry 12.20.2.1. Basic Metabolic Panel 12.20.2.2. Electrolyte Panel 12.20.2.3. Liver Panel 12.20.2.4. Lipid Profile 12.20.2.5. Renal Profile 12.20.2.6. Thyroid Function Panel 12.20.2.7. Specialty Chemicals 12.20.3. Molecular Diagnostics 12.20.3.1. Polymerase Chain Reaction (PCR) 12.20.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 12.20.3.3. Hybridization (In-situ Hybridization & FISH) 12.20.3.4. DNA Sequencing & NGS 12.20.3.5. Microarray 12.20.3.6. Others 12.20.4. Microbiology 12.20.5. Hematology 12.20.6. Coagulation & Hemostasis 12.20.7. Urinalysis 12.20.8. Others 12.21. Canada In-Vitro Diagnostics (IVD) Market Forecast, by Application 12.21.1. Food Processing 12.21.2. Dressing and Sauces 12.21.3. Ready Meals 12.21.4. Snacks & Savory Products 12.21.5. Infant Foods 12.21.6. Soups 12.21.7. Others 12.22. North America In-Vitro Diagnostics (IVD) Market Attractiveness Analysis 12.22.1. By Product 12.22.2. By End User 12.22.3. By Technology 12.22.4. By Application 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe In-Vitro Diagnostics (IVD) Market Analysis 13.1. Key Findings 13.2. Europe In-Vitro Diagnostics (IVD) Market Overview 13.3. Europe In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Product 13.4. Europe In-Vitro Diagnostics (IVD) Market Forecast, by Product 13.4.1. Reagents & Kits 13.4.2. Instruments 13.4.2.1. Fully-automated Instruments 13.4.2.2. Semi-automated Instruments 13.4.2.3. Others 13.4.3. Data Management Software 13.4.4. Services 13.5. Europe In-Vitro Diagnostics (IVD) Market Value Share Analysis, by End User 13.6. Europe In-Vitro Diagnostics (IVD) Market Forecast, by End User 13.6.1. Laboratories 13.6.1.1. Large/Reference Laboratories 13.6.1.2. Small & Medium-sized Laboratories 13.6.2. Hospitals 13.6.3. Academics 13.6.4. Point-Of-Care Testing 13.6.5. Patient Self-Testing 13.6.6. Others 13.7. Europe In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Technology 13.8. Europe In-Vitro Diagnostics (IVD) Market Forecast, by Technology 13.8.1. Immunochemistry 13.8.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 13.8.1.2. Radioimmunoassays (RIA) 13.8.1.3. Rapid Tests 13.8.1.4. Western Blot 13.8.1.5. ELISPOT 13.8.2. Clinical chemistry 13.8.2.1. Basic Metabolic Panel 13.8.2.2. Electrolyte Panel 13.8.2.3. Liver Panel 13.8.2.4. Lipid Profile 13.8.2.5. Renal Profile 13.8.2.6. Thyroid Function Panel 13.8.2.7. Specialty Chemicals 13.8.3. Molecular Diagnostics 13.8.3.1. Polymerase Chain Reaction (PCR) 13.8.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.8.3.3. Hybridization (In-situ Hybridization & FISH) 13.8.3.4. DNA Sequencing & NGS 13.8.3.5. Microarray 13.8.3.6. Others 13.8.4. Microbiology 13.8.5. Hematology 13.8.6. Coagulation & Hemostasis 13.8.7. Urinalysis 13.8.8. Others 13.9. Europe In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Application 13.10. Europe In-Vitro Diagnostics (IVD) Market Forecast, by Application 13.10.1. Food Processing 13.10.2. Dressing and Sauces 13.10.3. Ready Meals 13.10.4. Snacks & Savory Products 13.10.5. Infant Foods 13.10.6. Soups 13.10.7. Others 13.11. Europe In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Country 13.12. Europe In-Vitro Diagnostics (IVD) Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe In-Vitro Diagnostics (IVD) Market Analysis, by Country 13.14. Germany In-Vitro Diagnostics (IVD) Market Forecast, by Product 13.14.1. Reagents & Kits 13.14.2. Instruments 13.14.2.1. Fully-automated Instruments 13.14.2.2. Semi-automated Instruments 13.14.2.3. Others 13.14.3. Data Management Software 13.14.4. Services 13.15. Germany In-Vitro Diagnostics (IVD) Market Forecast, by End User 13.15.1. Laboratories 13.15.1.1. Large/Reference Laboratories 13.15.1.2. Small & Medium-sized Laboratories 13.15.2. Hospitals 13.15.3. Academics 13.15.4. Point-Of-Care Testing 13.15.5. Patient Self-Testing 13.15.6. Others 13.16. Germany In-Vitro Diagnostics (IVD) Market Forecast, by Technology 13.16.1. Immunochemistry 13.16.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 13.16.1.2. Radioimmunoassays (RIA) 13.16.1.3. Rapid Tests 13.16.1.4. Western Blot 13.16.1.5. ELISPOT 13.16.2. Clinical chemistry 13.16.2.1. Basic Metabolic Panel 13.16.2.2. Electrolyte Panel 13.16.2.3. Liver Panel 13.16.2.4. Lipid Profile 13.16.2.5. Renal Profile 13.16.2.6. Thyroid Function Panel 13.16.2.7. Specialty Chemicals 13.16.3. Molecular Diagnostics 13.16.3.1. Polymerase Chain Reaction (PCR) 13.16.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.16.3.3. Hybridization (In-situ Hybridization & FISH) 13.16.3.4. DNA Sequencing & NGS 13.16.3.5. Microarray 13.16.3.6. Others 13.16.4. Microbiology 13.16.5. Hematology 13.16.6. Coagulation & Hemostasis 13.16.7. Urinalysis 13.16.8. Others 13.17. Germany In-Vitro Diagnostics (IVD) Market Forecast, by Application 13.17.1. Food Processing 13.17.2. Dressing and Sauces 13.17.3. Ready Meals 13.17.4. Snacks & Savory Products 13.17.5. Infant Foods 13.17.6. Soups 13.17.7. Others 13.18. U.K. In-Vitro Diagnostics (IVD) Market Forecast, by Product 13.18.1. Reagents & Kits 13.18.2. Instruments 13.18.2.1. Fully-automated Instruments 13.18.2.2. Semi-automated Instruments 13.18.2.3. Others 13.18.3. Data Management Software 13.18.4. Services 13.19. U.K. In-Vitro Diagnostics (IVD) Market Forecast, by End User 13.19.1. Laboratories 13.19.1.1. Large/Reference Laboratories 13.19.1.2. Small & Medium-sized Laboratories 13.19.2. Hospitals 13.19.3. Academics 13.19.4. Point-Of-Care Testing 13.19.5. Patient Self-Testing 13.19.6. Others 13.20. U.K. In-Vitro Diagnostics (IVD) Market Forecast, by Technology 13.20.1. Immunochemistry 13.20.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 13.20.1.2. Radioimmunoassays (RIA) 13.20.1.3. Rapid Tests 13.20.1.4. Western Blot 13.20.1.5. ELISPOT 13.20.2. Clinical chemistry 13.20.2.1. Basic Metabolic Panel 13.20.2.2. Electrolyte Panel 13.20.2.3. Liver Panel 13.20.2.4. Lipid Profile 13.20.2.5. Renal Profile 13.20.2.6. Thyroid Function Panel 13.20.2.7. Specialty Chemicals 13.20.3. Molecular Diagnostics 13.20.3.1. Polymerase Chain Reaction (PCR) 13.20.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.20.3.3. Hybridization (In-situ Hybridization & FISH) 13.20.3.4. DNA Sequencing & NGS 13.20.3.5. Microarray 13.20.3.6. Others 13.20.4. Microbiology 13.20.5. Hematology 13.20.6. Coagulation & Hemostasis 13.20.7. Urinalysis 13.20.8. Others 13.21. U.K. In-Vitro Diagnostics (IVD) Market Forecast, by Application 13.21.1. Food Processing 13.21.2. Dressing and Sauces 13.21.3. Ready Meals 13.21.4. Snacks & Savory Products 13.21.5. Infant Foods 13.21.6. Soups 13.21.7. Others 13.22. France In-Vitro Diagnostics (IVD) Market Forecast, by Product 13.22.1. Reagents & Kits 13.22.2. Instruments 13.22.2.1. Fully-automated Instruments 13.22.2.2. Semi-automated Instruments 13.22.2.3. Others 13.22.3. Data Management Software 13.22.4. Services 13.23. France In-Vitro Diagnostics (IVD) Market Forecast, by End User 13.23.1. Laboratories 13.23.1.1. Large/Reference Laboratories 13.23.1.2. Small & Medium-sized Laboratories 13.23.2. Hospitals 13.23.3. Academics 13.23.4. Point-Of-Care Testing 13.23.5. Patient Self-Testing 13.23.6. Others 13.24. France In-Vitro Diagnostics (IVD) Market Forecast, by Technology 13.24.1. Immunochemistry 13.24.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 13.24.1.2. Radioimmunoassays (RIA) 13.24.1.3. Rapid Tests 13.24.1.4. Western Blot 13.24.1.5. ELISPOT 13.24.2. Clinical chemistry 13.24.2.1. Basic Metabolic Panel 13.24.2.2. Electrolyte Panel 13.24.2.3. Liver Panel 13.24.2.4. Lipid Profile 13.24.2.5. Renal Profile 13.24.2.6. Thyroid Function Panel 13.24.2.7. Specialty Chemicals 13.24.3. Molecular Diagnostics 13.24.3.1. Polymerase Chain Reaction (PCR) 13.24.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.24.3.3. Hybridization (In-situ Hybridization & FISH) 13.24.3.4. DNA Sequencing & NGS 13.24.3.5. Microarray 13.24.3.6. Others 13.24.4. Microbiology 13.24.5. Hematology 13.24.6. Coagulation & Hemostasis 13.24.7. Urinalysis 13.24.8. Others 13.25. France In-Vitro Diagnostics (IVD) Market Forecast, by Application 13.25.1. Food Processing 13.25.2. Dressing and Sauces 13.25.3. Ready Meals 13.25.4. Snacks & Savory Products 13.25.5. Infant Foods 13.25.6. Soups 13.25.7. Others 13.26. Italy In-Vitro Diagnostics (IVD) Market Forecast, by Product 13.26.1. Reagents & Kits 13.26.2. Instruments 13.26.2.1. Fully-automated Instruments 13.26.2.2. Semi-automated Instruments 13.26.2.3. Others 13.26.3. Data Management Software 13.26.4. Services 13.27. Italy In-Vitro Diagnostics (IVD) Market Forecast, by End User 13.27.1. Laboratories 13.27.1.1. Large/Reference Laboratories 13.27.1.2. Small & Medium-sized Laboratories 13.27.2. Hospitals 13.27.3. Academics 13.27.4. Point-Of-Care Testing 13.27.5. Patient Self-Testing 13.27.6. Others 13.28. Italy In-Vitro Diagnostics (IVD) Market Forecast, by Technology 13.28.1. Immunochemistry 13.28.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 13.28.1.2. Radioimmunoassays (RIA) 13.28.1.3. Rapid Tests 13.28.1.4. Western Blot 13.28.1.5. ELISPOT 13.28.2. Clinical chemistry 13.28.2.1. Basic Metabolic Panel 13.28.2.2. Electrolyte Panel 13.28.2.3. Liver Panel 13.28.2.4. Lipid Profile 13.28.2.5. Renal Profile 13.28.2.6. Thyroid Function Panel 13.28.2.7. Specialty Chemicals 13.28.3. Molecular Diagnostics 13.28.3.1. Polymerase Chain Reaction (PCR) 13.28.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.28.3.3. Hybridization (In-situ Hybridization & FISH) 13.28.3.4. DNA Sequencing & NGS 13.28.3.5. Microarray 13.28.3.6. Others 13.28.4. Microbiology 13.28.5. Hematology 13.28.6. Coagulation & Hemostasis 13.28.7. Urinalysis 13.28.8. Others 13.29. Italy In-Vitro Diagnostics (IVD) Market Forecast, by Application 13.29.1. Food Processing 13.29.2. Dressing and Sauces 13.29.3. Ready Meals 13.29.4. Snacks & Savory Products 13.29.5. Infant Foods 13.29.6. Soups 13.29.7. Others 13.30. Spain In-Vitro Diagnostics (IVD) Market Forecast, by Product 13.30.1. Reagents & Kits 13.30.2. Instruments 13.30.2.1. Fully-automated Instruments 13.30.2.2. Semi-automated Instruments 13.30.2.3. Others 13.30.3. Data Management Software 13.30.4. Services 13.31. Spain In-Vitro Diagnostics (IVD) Market Forecast, by End User 13.31.1. Laboratories 13.31.1.1. Large/Reference Laboratories 13.31.1.2. Small & Medium-sized Laboratories 13.31.2. Hospitals 13.31.3. Academics 13.31.4. Point-Of-Care Testing 13.31.5. Patient Self-Testing 13.31.6. Others 13.32. Spain In-Vitro Diagnostics (IVD) Market Forecast, by Technology 13.32.1. Immunochemistry 13.32.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 13.32.1.2. Radioimmunoassays (RIA) 13.32.1.3. Rapid Tests 13.32.1.4. Western Blot 13.32.1.5. ELISPOT 13.32.2. Clinical chemistry 13.32.2.1. Basic Metabolic Panel 13.32.2.2. Electrolyte Panel 13.32.2.3. Liver Panel 13.32.2.4. Lipid Profile 13.32.2.5. Renal Profile 13.32.2.6. Thyroid Function Panel 13.32.2.7. Specialty Chemicals 13.32.3. Molecular Diagnostics 13.32.3.1. Polymerase Chain Reaction (PCR) 13.32.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.32.3.3. Hybridization (In-situ Hybridization & FISH) 13.32.3.4. DNA Sequencing & NGS 13.32.3.5. Microarray 13.32.3.6. Others 13.32.4. Microbiology 13.32.5. Hematology 13.32.6. Coagulation & Hemostasis 13.32.7. Urinalysis 13.32.8. Others 13.33. Spain In-Vitro Diagnostics (IVD) Market Forecast, by Application 13.33.1. Food Processing 13.33.2. Dressing and Sauces 13.33.3. Ready Meals 13.33.4. Snacks & Savory Products 13.33.5. Infant Foods 13.33.6. Soups 13.33.7. Others 13.34. Rest of Europe In-Vitro Diagnostics (IVD) Market Forecast, by Product 13.34.1. Reagents & Kits 13.34.2. Instruments 13.34.2.1. Fully-automated Instruments 13.34.2.2. Semi-automated Instruments 13.34.2.3. Others 13.34.3. Data Management Software 13.34.4. Services 13.35. Rest of Europe In-Vitro Diagnostics (IVD) Market Forecast, by End User 13.35.1. Laboratories 13.35.1.1. Large/Reference Laboratories 13.35.1.2. Small & Medium-sized Laboratories 13.35.2. Hospitals 13.35.3. Academics 13.35.4. Point-Of-Care Testing 13.35.5. Patient Self-Testing 13.35.6. Others 13.36. Rest of Europe In-Vitro Diagnostics (IVD) Market Forecast, by Technology 13.36.1. Immunochemistry 13.36.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 13.36.1.2. Radioimmunoassays (RIA) 13.36.1.3. Rapid Tests 13.36.1.4. Western Blot 13.36.1.5. ELISPOT 13.36.2. Clinical chemistry 13.36.2.1. Basic Metabolic Panel 13.36.2.2. Electrolyte Panel 13.36.2.3. Liver Panel 13.36.2.4. Lipid Profile 13.36.2.5. Renal Profile 13.36.2.6. Thyroid Function Panel 13.36.2.7. Specialty Chemicals 13.36.3. Molecular Diagnostics 13.36.3.1. Polymerase Chain Reaction (PCR) 13.36.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 13.36.3.3. Hybridization (In-situ Hybridization & FISH) 13.36.3.4. DNA Sequencing & NGS 13.36.3.5. Microarray 13.36.3.6. Others 13.36.4. Microbiology 13.36.5. Hematology 13.36.6. Coagulation & Hemostasis 13.36.7. Urinalysis 13.36.8. Others 13.37. Rest Of Europe In-Vitro Diagnostics (IVD) Market Forecast, by Application 13.37.1. Food Processing 13.37.2. Dressing and Sauces 13.37.3. Ready Meals 13.37.4. Snacks & Savory Products 13.37.5. Infant Foods 13.37.6. Soups 13.37.7. Others 13.38. Europe In-Vitro Diagnostics (IVD) Market Attractiveness Analysis 13.38.1. By Product 13.38.2. By End User 13.38.3. By Technology 13.38.4. By Application 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific In-Vitro Diagnostics (IVD) Market Analysis 14.1. Key Findings 14.2. Asia Pacific In-Vitro Diagnostics (IVD) Market Overview 14.3. Asia Pacific In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Product 14.4. Asia Pacific In-Vitro Diagnostics (IVD) Market Forecast, by Product 14.4.1. Reagents & Kits 14.4.2. Instruments 14.4.2.1. Fully-automated Instruments 14.4.2.2. Semi-automated Instruments 14.4.2.3. Others 14.4.3. Data Management Software 14.4.4. Services 14.5. Asia Pacific In-Vitro Diagnostics (IVD) Market Value Share Analysis, by End User 14.6. Asia Pacific In-Vitro Diagnostics (IVD) Market Forecast, by End User 14.6.1. Laboratories 14.6.1.1. Large/Reference Laboratories 14.6.1.2. Small & Medium-sized Laboratories 14.6.2. Hospitals 14.6.3. Academics 14.6.4. Point-Of-Care Testing 14.6.5. Patient Self-Testing 14.6.6. Others 14.7. Asia Pacific In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Technology 14.8. Asia Pacific In-Vitro Diagnostics (IVD) Market Forecast, by Technology 14.8.1. Immunochemistry 14.8.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 14.8.1.2. Radioimmunoassays (RIA) 14.8.1.3. Rapid Tests 14.8.1.4. Western Blot 14.8.1.5. ELISPOT 14.8.2. Clinical chemistry 14.8.2.1. Basic Metabolic Panel 14.8.2.2. Electrolyte Panel 14.8.2.3. Liver Panel 14.8.2.4. Lipid Profile 14.8.2.5. Renal Profile 14.8.2.6. Thyroid Function Panel 14.8.2.7. Specialty Chemicals 14.8.3. Molecular Diagnostics 14.8.3.1. Polymerase Chain Reaction (PCR) 14.8.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.8.3.3. Hybridization (In-situ Hybridization & FISH) 14.8.3.4. DNA Sequencing & NGS 14.8.3.5. Microarray 14.8.3.6. Others 14.8.4. Microbiology 14.8.5. Hematology 14.8.6. Coagulation & Hemostasis 14.8.7. Urinalysis 14.8.8. Others 14.9. Asia Pacific In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Application 14.10. Asia Pacific In-Vitro Diagnostics (IVD) Market Forecast, by Application 14.10.1. Food Processing 14.10.2. Dressing and Sauces 14.10.3. Ready Meals 14.10.4. Snacks & Savory Products 14.10.5. Infant Foods 14.10.6. Soups 14.10.7. Others 14.11. Asia Pacific In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Country 14.12. Asia Pacific In-Vitro Diagnostics (IVD) Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific In-Vitro Diagnostics (IVD) Market Analysis, by Country 14.14. China In-Vitro Diagnostics (IVD) Market Forecast, by Product 14.14.1. Reagents & Kits 14.14.2. Instruments 14.14.2.1. Fully-automated Instruments 14.14.2.2. Semi-automated Instruments 14.14.2.3. Others 14.14.3. Data Management Software 14.14.4. Services 14.15. China In-Vitro Diagnostics (IVD) Market Forecast, by End User 14.15.1. Laboratories 14.15.1.1. Large/Reference Laboratories 14.15.1.2. Small & Medium-sized Laboratories 14.15.2. Hospitals 14.15.3. Academics 14.15.4. Point-Of-Care Testing 14.15.5. Patient Self-Testing 14.15.6. Others 14.16. China In-Vitro Diagnostics (IVD) Market Forecast, by Technology 14.16.1. Immunochemistry 14.16.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 14.16.1.2. Radioimmunoassays (RIA) 14.16.1.3. Rapid Tests 14.16.1.4. Western Blot 14.16.1.5. ELISPOT 14.16.2. Clinical chemistry 14.16.2.1. Basic Metabolic Panel 14.16.2.2. Electrolyte Panel 14.16.2.3. Liver Panel 14.16.2.4. Lipid Profile 14.16.2.5. Renal Profile 14.16.2.6. Thyroid Function Panel 14.16.2.7. Specialty Chemicals 14.16.3. Molecular Diagnostics 14.16.3.1. Polymerase Chain Reaction (PCR) 14.16.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.16.3.3. Hybridization (In-situ Hybridization & FISH) 14.16.3.4. DNA Sequencing & NGS 14.16.3.5. Microarray 14.16.3.6. Others 14.16.4. Microbiology 14.16.5. Hematology 14.16.6. Coagulation & Hemostasis 14.16.7. Urinalysis 14.16.8. Others 14.17. China In-Vitro Diagnostics (IVD) Market Forecast, by Application 14.17.1. Food Processing 14.17.2. Dressing and Sauces 14.17.3. Ready Meals 14.17.4. Snacks & Savory Products 14.17.5. Infant Foods 14.17.6. Soups 14.17.7. Others 14.18. India In-Vitro Diagnostics (IVD) Market Forecast, by Product 14.18.1. Reagents & Kits 14.18.2. Instruments 14.18.2.1. Fully-automated Instruments 14.18.2.2. Semi-automated Instruments 14.18.2.3. Others 14.18.3. Data Management Software 14.18.4. Services 14.19. India In-Vitro Diagnostics (IVD) Market Forecast, by End User 14.19.1. Laboratories 14.19.1.1. Large/Reference Laboratories 14.19.1.2. Small & Medium-sized Laboratories 14.19.2. Hospitals 14.19.3. Academics 14.19.4. Point-Of-Care Testing 14.19.5. Patient Self-Testing 14.19.6. Others 14.20. India In-Vitro Diagnostics (IVD) Market Forecast, by Technology 14.20.1. Immunochemistry 14.20.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 14.20.1.2. Radioimmunoassays (RIA) 14.20.1.3. Rapid Tests 14.20.1.4. Western Blot 14.20.1.5. ELISPOT 14.20.2. Clinical chemistry 14.20.2.1. Basic Metabolic Panel 14.20.2.2. Electrolyte Panel 14.20.2.3. Liver Panel 14.20.2.4. Lipid Profile 14.20.2.5. Renal Profile 14.20.2.6. Thyroid Function Panel 14.20.2.7. Specialty Chemicals 14.20.3. Molecular Diagnostics 14.20.3.1. Polymerase Chain Reaction (PCR) 14.20.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.20.3.3. Hybridization (In-situ Hybridization & FISH) 14.20.3.4. DNA Sequencing & NGS 14.20.3.5. Microarray 14.20.3.6. Others 14.20.4. Microbiology 14.20.5. Hematology 14.20.6. Coagulation & Hemostasis 14.20.7. Urinalysis 14.20.8. Others 14.21. India In-Vitro Diagnostics (IVD) Market Forecast, by Application 14.21.1. Food Processing 14.21.2. Dressing and Sauces 14.21.3. Ready Meals 14.21.4. Snacks & Savory Products 14.21.5. Infant Foods 14.21.6. Soups 14.21.7. Others 14.22. Japan In-Vitro Diagnostics (IVD) Market Forecast, by Product 14.22.1. Reagents & Kits 14.22.2. Instruments 14.22.2.1. Fully-automated Instruments 14.22.2.2. Semi-automated Instruments 14.22.2.3. Others 14.22.3. Data Management Software 14.22.4. Services 14.23. Japan In-Vitro Diagnostics (IVD) Market Forecast, by End User 14.23.1. Laboratories 14.23.1.1. Large/Reference Laboratories 14.23.1.2. Small & Medium-sized Laboratories 14.23.2. Hospitals 14.23.3. Academics 14.23.4. Point-Of-Care Testing 14.23.5. Patient Self-Testing 14.23.6. Others 14.24. Japan In-Vitro Diagnostics (IVD) Market Forecast, by Technology 14.24.1. Immunochemistry 14.24.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 14.24.1.2. Radioimmunoassays (RIA) 14.24.1.3. Rapid Tests 14.24.1.4. Western Blot 14.24.1.5. ELISPOT 14.24.2. Clinical chemistry 14.24.2.1. Basic Metabolic Panel 14.24.2.2. Electrolyte Panel 14.24.2.3. Liver Panel 14.24.2.4. Lipid Profile 14.24.2.5. Renal Profile 14.24.2.6. Thyroid Function Panel 14.24.2.7. Specialty Chemicals 14.24.3. Molecular Diagnostics 14.24.3.1. Polymerase Chain Reaction (PCR) 14.24.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.24.3.3. Hybridization (In-situ Hybridization & FISH) 14.24.3.4. DNA Sequencing & NGS 14.24.3.5. Microarray 14.24.3.6. Others 14.24.4. Microbiology 14.24.5. Hematology 14.24.6. Coagulation & Hemostasis 14.24.7. Urinalysis 14.24.8. Others 14.25. Japan In-Vitro Diagnostics (IVD) Market Forecast, by Application 14.25.1. Food Processing 14.25.2. Dressing and Sauces 14.25.3. Ready Meals 14.25.4. Snacks & Savory Products 14.25.5. Infant Foods 14.25.6. Soups 14.25.7. Others 14.26. ASEAN In-Vitro Diagnostics (IVD) Market Forecast, by Product 14.26.1. Reagents & Kits 14.26.2. Instruments 14.26.2.1. Fully-automated Instruments 14.26.2.2. Semi-automated Instruments 14.26.2.3. Others 14.26.3. Data Management Software 14.26.4. Services 14.27. ASEAN In-Vitro Diagnostics (IVD) Market Forecast, by End User 14.27.1. Laboratories 14.27.1.1. Large/Reference Laboratories 14.27.1.2. Small & Medium-sized Laboratories 14.27.2. Hospitals 14.27.3. Academics 14.27.4. Point-Of-Care Testing 14.27.5. Patient Self-Testing 14.27.6. Others 14.28. ASEAN In-Vitro Diagnostics (IVD) Market Forecast, by Technology 14.28.1. Immunochemistry 14.28.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 14.28.1.2. Radioimmunoassays (RIA) 14.28.1.3. Rapid Tests 14.28.1.4. Western Blot 14.28.1.5. ELISPOT 14.28.2. Clinical chemistry 14.28.2.1. Basic Metabolic Panel 14.28.2.2. Electrolyte Panel 14.28.2.3. Liver Panel 14.28.2.4. Lipid Profile 14.28.2.5. Renal Profile 14.28.2.6. Thyroid Function Panel 14.28.2.7. Specialty Chemicals 14.28.3. Molecular Diagnostics 14.28.3.1. Polymerase Chain Reaction (PCR) 14.28.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.28.3.3. Hybridization (In-situ Hybridization & FISH) 14.28.3.4. DNA Sequencing & NGS 14.28.3.5. Microarray 14.28.3.6. Others 14.28.4. Microbiology 14.28.5. Hematology 14.28.6. Coagulation & Hemostasis 14.28.7. Urinalysis 14.28.8. Others 14.29. ASEAN In-Vitro Diagnostics (IVD) Market Forecast, by Application 14.29.1. Food Processing 14.29.2. Dressing and Sauces 14.29.3. Ready Meals 14.29.4. Snacks & Savory Products 14.29.5. Infant Foods 14.29.6. Soups 14.29.7. Others 14.30. Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market Forecast, by Product 14.30.1. White Onions 14.30.2. Red Onions 14.30.3. Pink Onions 14.30.4. Hybrid 14.31. Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market Forecast, by End User 14.31.1. Laboratories 14.31.1.1. Large/Reference Laboratories 14.31.1.2. Small & Medium-sized Laboratories 14.31.2. Hospitals 14.31.3. Academics 14.31.4. Point-Of-Care Testing 14.31.5. Patient Self-Testing 14.31.6. Others 14.32. Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market Forecast, by Technology 14.32.1. Immunochemistry 14.32.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 14.32.1.2. Radioimmunoassays (RIA) 14.32.1.3. Rapid Tests 14.32.1.4. Western Blot 14.32.1.5. ELISPOT 14.32.2. Clinical chemistry 14.32.2.1. Basic Metabolic Panel 14.32.2.2. Electrolyte Panel 14.32.2.3. Liver Panel 14.32.2.4. Lipid Profile 14.32.2.5. Renal Profile 14.32.2.6. Thyroid Function Panel 14.32.2.7. Specialty Chemicals 14.32.3. Molecular Diagnostics 14.32.3.1. Polymerase Chain Reaction (PCR) 14.32.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 14.32.3.3. Hybridization (In-situ Hybridization & FISH) 14.32.3.4. DNA Sequencing & NGS 14.32.3.5. Microarray 14.32.3.6. Others 14.32.4. Microbiology 14.32.5. Hematology 14.32.6. Coagulation & Hemostasis 14.32.7. Urinalysis 14.32.8. Others 14.33. Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market Forecast, by Application 14.33.1. Food Processing 14.33.2. Dressing and Sauces 14.33.3. Ready Meals 14.33.4. Snacks & Savory Products 14.33.5. Infant Foods 14.33.6. Soups 14.33.7. Others 14.34. Asia Pacific In-Vitro Diagnostics (IVD) Market Attractiveness Analysis 14.34.1. By Product 14.34.2. By End User 14.34.3. By Technology 14.34.4. By Application 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa In-Vitro Diagnostics (IVD) Market Analysis 15.1. Key Findings 15.2. Middle East & Africa In-Vitro Diagnostics (IVD) Market Overview 15.3. Middle East & Africa In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Product 15.4. Middle East & Africa In-Vitro Diagnostics (IVD) Market Forecast, by Product 15.4.1. Reagents & Kits 15.4.2. Instruments 15.4.2.1. Fully-automated Instruments 15.4.2.2. Semi-automated Instruments 15.4.2.3. Others 15.4.3. Data Management Software 15.4.4. Services 15.5. Middle East & Africa In-Vitro Diagnostics (IVD) Market Value Share Analysis, by End User 15.6. Middle East & Africa In-Vitro Diagnostics (IVD) Market Forecast, by End User 15.6.1. Laboratories 15.6.1.1. Large/Reference Laboratories 15.6.1.2. Small & Medium-sized Laboratories 15.6.2. Hospitals 15.6.3. Academics 15.6.4. Point-Of-Care Testing 15.6.5. Patient Self-Testing 15.6.6. Others 15.7. Middle East & Africa In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Technology 15.8. Middle East & Africa In-Vitro Diagnostics (IVD) Market Forecast, by Technology 15.8.1. Immunochemistry 15.8.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 15.8.1.2. Radioimmunoassays (RIA) 15.8.1.3. Rapid Tests 15.8.1.4. Western Blot 15.8.1.5. ELISPOT 15.8.2. Clinical chemistry 15.8.2.1. Basic Metabolic Panel 15.8.2.2. Electrolyte Panel 15.8.2.3. Liver Panel 15.8.2.4. Lipid Profile 15.8.2.5. Renal Profile 15.8.2.6. Thyroid Function Panel 15.8.2.7. Specialty Chemicals 15.8.3. Molecular Diagnostics 15.8.3.1. Polymerase Chain Reaction (PCR) 15.8.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 15.8.3.3. Hybridization (In-situ Hybridization & FISH) 15.8.3.4. DNA Sequencing & NGS 15.8.3.5. Microarray 15.8.3.6. Others 15.8.4. Microbiology 15.8.5. Hematology 15.8.6. Coagulation & Hemostasis 15.8.7. Urinalysis 15.8.8. Others 15.9. Middle East & Africa In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Application 15.10. Middle East & Africa In-Vitro Diagnostics (IVD) Market Forecast, by Application 15.10.1. Food Processing 15.10.2. Dressing and Sauces 15.10.3. Ready Meals 15.10.4. Snacks & Savory Products 15.10.5. Infant Foods 15.10.6. Soups 15.10.7. Others 15.11. Middle East & Africa In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Country 15.12. Middle East & Africa In-Vitro Diagnostics (IVD) Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa In-Vitro Diagnostics (IVD) Market Analysis, by Country 15.14. GCC In-Vitro Diagnostics (IVD) Market Forecast, by Product 15.14.1. Reagents & Kits 15.14.2. Instruments 15.14.2.1. Fully-automated Instruments 15.14.2.2. Semi-automated Instruments 15.14.2.3. Others 15.14.3. Data Management Software 15.14.4. Services 15.15. GCC In-Vitro Diagnostics (IVD) Market Forecast, by End User 15.15.1. Laboratories 15.15.1.1. Large/Reference Laboratories 15.15.1.2. Small & Medium-sized Laboratories 15.15.2. Hospitals 15.15.3. Academics 15.15.4. Point-Of-Care Testing 15.15.5. Patient Self-Testing 15.15.6. Others 15.16. GCC In-Vitro Diagnostics (IVD) Market Forecast, by Technology 15.16.1. Immunochemistry 15.16.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 15.16.1.2. Radioimmunoassays (RIA) 15.16.1.3. Rapid Tests 15.16.1.4. Western Blot 15.16.1.5. ELISPOT 15.16.2. Clinical chemistry 15.16.2.1. Basic Metabolic Panel 15.16.2.2. Electrolyte Panel 15.16.2.3. Liver Panel 15.16.2.4. Lipid Profile 15.16.2.5. Renal Profile 15.16.2.6. Thyroid Function Panel 15.16.2.7. Specialty Chemicals 15.16.3. Molecular Diagnostics 15.16.3.1. Polymerase Chain Reaction (PCR) 15.16.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 15.16.3.3. Hybridization (In-situ Hybridization & FISH) 15.16.3.4. DNA Sequencing & NGS 15.16.3.5. Microarray 15.16.3.6. Others 15.16.4. Microbiology 15.16.5. Hematology 15.16.6. Coagulation & Hemostasis 15.16.7. Urinalysis 15.16.8. Others 15.17. GCC In-Vitro Diagnostics (IVD) Market Forecast, by Application 15.17.1. Food Processing 15.17.2. Dressing and Sauces 15.17.3. Ready Meals 15.17.4. Snacks & Savory Products 15.17.5. Infant Foods 15.17.6. Soups 15.17.7. Others 15.18. South Africa In-Vitro Diagnostics (IVD) Market Forecast, by Product 15.18.1. Reagents & Kits 15.18.2. Instruments 15.18.2.1. Fully-automated Instruments 15.18.2.2. Semi-automated Instruments 15.18.2.3. Others 15.18.3. Data Management Software 15.18.4. Services 15.19. South Africa In-Vitro Diagnostics (IVD) Market Forecast, by End User 15.19.1. Laboratories 15.19.1.1. Large/Reference Laboratories 15.19.1.2. Small & Medium-sized Laboratories 15.19.2. Hospitals 15.19.3. Academics 15.19.4. Point-Of-Care Testing 15.19.5. Patient Self-Testing 15.19.6. Others 15.20. South Africa In-Vitro Diagnostics (IVD) Market Forecast, by Technology 15.20.1. Immunochemistry 15.20.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 15.20.1.2. Radioimmunoassays (RIA) 15.20.1.3. Rapid Tests 15.20.1.4. Western Blot 15.20.1.5. ELISPOT 15.20.2. Clinical chemistry 15.20.2.1. Basic Metabolic Panel 15.20.2.2. Electrolyte Panel 15.20.2.3. Liver Panel 15.20.2.4. Lipid Profile 15.20.2.5. Renal Profile 15.20.2.6. Thyroid Function Panel 15.20.2.7. Specialty Chemicals 15.20.3. Molecular Diagnostics 15.20.3.1. Polymerase Chain Reaction (PCR) 15.20.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 15.20.3.3. Hybridization (In-situ Hybridization & FISH) 15.20.3.4. DNA Sequencing & NGS 15.20.3.5. Microarray 15.20.3.6. Others 15.20.4. Microbiology 15.20.5. Hematology 15.20.6. Coagulation & Hemostasis 15.20.7. Urinalysis 15.20.8. Others 15.21. South Africa In-Vitro Diagnostics (IVD) Market Forecast, by Application 15.21.1. Food Processing 15.21.2. Dressing and Sauces 15.21.3. Ready Meals 15.21.4. Snacks & Savory Products 15.21.5. Infant Foods 15.21.6. Soups 15.21.7. Others 15.22. Rest of Middle East & Africa In-Vitro Diagnostics (IVD) Market Forecast, by Product 15.22.1. Reagents & Kits 15.22.2. Instruments 15.22.2.1. Fully-automated Instruments 15.22.2.2. Semi-automated Instruments 15.22.2.3. Others 15.22.3. Data Management Software 15.22.4. Services 15.23. Rest of Middle East & Africa In-Vitro Diagnostics (IVD) Market Forecast, by End User 15.23.1. Laboratories 15.23.1.1. Large/Reference Laboratories 15.23.1.2. Small & Medium-sized Laboratories 15.23.2. Hospitals 15.23.3. Academics 15.23.4. Point-Of-Care Testing 15.23.5. Patient Self-Testing 15.23.6. Others 15.24. Rest of Middle East & Africa In-Vitro Diagnostics (IVD) Market Forecast, by Technology 15.24.1. Immunochemistry 15.24.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 15.24.1.2. Radioimmunoassays (RIA) 15.24.1.3. Rapid Tests 15.24.1.4. Western Blot 15.24.1.5. ELISPOT 15.24.2. Clinical chemistry 15.24.2.1. Basic Metabolic Panel 15.24.2.2. Electrolyte Panel 15.24.2.3. Liver Panel 15.24.2.4. Lipid Profile 15.24.2.5. Renal Profile 15.24.2.6. Thyroid Function Panel 15.24.2.7. Specialty Chemicals 15.24.3. Molecular Diagnostics 15.24.3.1. Polymerase Chain Reaction (PCR) 15.24.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 15.24.3.3. Hybridization (In-situ Hybridization & FISH) 15.24.3.4. DNA Sequencing & NGS 15.24.3.5. Microarray 15.24.3.6. Others 15.24.4. Microbiology 15.24.5. Hematology 15.24.6. Coagulation & Hemostasis 15.24.7. Urinalysis 15.24.8. Others 15.25. Rest of Middle East & Africa In-Vitro Diagnostics (IVD) Market Forecast, by Application 15.25.1. Food Processing 15.25.2. Dressing and Sauces 15.25.3. Ready Meals 15.25.4. Snacks & Savory Products 15.25.5. Infant Foods 15.25.6. Soups 15.25.7. Others 15.26. Middle East & Africa In-Vitro Diagnostics (IVD) Market Attractiveness Analysis 15.26.1. By Product 15.26.2. By End User 15.26.3. By Technology 15.26.4. By Application 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America In-Vitro Diagnostics (IVD) Market Analysis 16.1. Key Findings 16.2. South America In-Vitro Diagnostics (IVD) Market Overview 16.3. South America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Product 16.4. South America In-Vitro Diagnostics (IVD) Market Forecast, by Product 16.4.1. Reagents & Kits 16.4.2. Instruments 16.4.2.1. Fully-automated Instruments 16.4.2.2. Semi-automated Instruments 16.4.2.3. Others 16.4.3. Data Management Software 16.4.4. Services 16.5. South America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by End User 16.6. South America In-Vitro Diagnostics (IVD) Market Forecast, by End User 16.6.1. Laboratories 16.6.1.1. Large/Reference Laboratories 16.6.1.2. Small & Medium-sized Laboratories 16.6.2. Hospitals 16.6.3. Academics 16.6.4. Point-Of-Care Testing 16.6.5. Patient Self-Testing 16.6.6. Others 16.7. South America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Technology 16.8. South America In-Vitro Diagnostics (IVD) Market Forecast, by Technology 16.8.1. Immunochemistry 16.8.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 16.8.1.2. Radioimmunoassays (RIA) 16.8.1.3. Rapid Tests 16.8.1.4. Western Blot 16.8.1.5. ELISPOT 16.8.2. Clinical chemistry 16.8.2.1. Basic Metabolic Panel 16.8.2.2. Electrolyte Panel 16.8.2.3. Liver Panel 16.8.2.4. Lipid Profile 16.8.2.5. Renal Profile 16.8.2.6. Thyroid Function Panel 16.8.2.7. Specialty Chemicals 16.8.3. Molecular Diagnostics 16.8.3.1. Polymerase Chain Reaction (PCR) 16.8.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 16.8.3.3. Hybridization (In-situ Hybridization & FISH) 16.8.3.4. DNA Sequencing & NGS 16.8.3.5. Microarray 16.8.3.6. Others 16.8.4. Microbiology 16.8.5. Hematology 16.8.6. Coagulation & Hemostasis 16.8.7. Urinalysis 16.8.8. Others 16.9. South America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Application 16.10. South America In-Vitro Diagnostics (IVD) Market Forecast, by Application 16.10.1. Food Processing 16.10.2. Dressing and Sauces 16.10.3. Ready Meals 16.10.4. Snacks & Savory Products 16.10.5. Infant Foods 16.10.6. Soups 16.10.7. Others 16.11. South America In-Vitro Diagnostics (IVD) Market Value Share Analysis, by Country 16.12. South America In-Vitro Diagnostics (IVD) Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America In-Vitro Diagnostics (IVD) Market Analysis, by Country 16.14. Brazil In-Vitro Diagnostics (IVD) Market Forecast, by Product 16.14.1. Reagents & Kits 16.14.2. Instruments 16.14.2.1. Fully-automated Instruments 16.14.2.2. Semi-automated Instruments 16.14.2.3. Others 16.14.3. Data Management Software 16.14.4. Services 16.15. Brazil In-Vitro Diagnostics (IVD) Market Forecast, by End User 16.15.1. Laboratories 16.15.1.1. Large/Reference Laboratories 16.15.1.2. Small & Medium-sized Laboratories 16.15.2. Hospitals 16.15.3. Academics 16.15.4. Point-Of-Care Testing 16.15.5. Patient Self-Testing 16.15.6. Others 16.16. Brazil In-Vitro Diagnostics (IVD) Market Forecast, by Technology 16.16.1. Immunochemistry 16.16.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 16.16.1.2. Radioimmunoassays (RIA) 16.16.1.3. Rapid Tests 16.16.1.4. Western Blot 16.16.1.5. ELISPOT 16.16.2. Clinical chemistry 16.16.2.1. Basic Metabolic Panel 16.16.2.2. Electrolyte Panel 16.16.2.3. Liver Panel 16.16.2.4. Lipid Profile 16.16.2.5. Renal Profile 16.16.2.6. Thyroid Function Panel 16.16.2.7. Specialty Chemicals 16.16.3. Molecular Diagnostics 16.16.3.1. Polymerase Chain Reaction (PCR) 16.16.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 16.16.3.3. Hybridization (In-situ Hybridization & FISH) 16.16.3.4. DNA Sequencing & NGS 16.16.3.5. Microarray 16.16.3.6. Others 16.16.4. Microbiology 16.16.5. Hematology 16.16.6. Coagulation & Hemostasis 16.16.7. Urinalysis 16.16.8. Others 16.17. Brazil In-Vitro Diagnostics (IVD) Market Forecast, by Application 16.17.1. Food Processing 16.17.2. Dressing and Sauces 16.17.3. Ready Meals 16.17.4. Snacks & Savory Products 16.17.5. Infant Foods 16.17.6. Soups 16.17.7. Others 16.18. Mexico In-Vitro Diagnostics (IVD) Market Forecast, by Product 16.18.1. Reagents & Kits 16.18.2. Instruments 16.18.2.1. Fully-automated Instruments 16.18.2.2. Semi-automated Instruments 16.18.2.3. Others 16.18.3. Data Management Software 16.18.4. Services 16.19. Mexico In-Vitro Diagnostics (IVD) Market Forecast, by End User 16.19.1. Laboratories 16.19.1.1. Large/Reference Laboratories 16.19.1.2. Small & Medium-sized Laboratories 16.19.2. Hospitals 16.19.3. Academics 16.19.4. Point-Of-Care Testing 16.19.5. Patient Self-Testing 16.19.6. Others 16.20. Mexico In-Vitro Diagnostics (IVD) Market Forecast, by Technology 16.20.1. Immunochemistry 16.20.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 16.20.1.2. Radioimmunoassays (RIA) 16.20.1.3. Rapid Tests 16.20.1.4. Western Blot 16.20.1.5. ELISPOT 16.20.2. Clinical chemistry 16.20.2.1. Basic Metabolic Panel 16.20.2.2. Electrolyte Panel 16.20.2.3. Liver Panel 16.20.2.4. Lipid Profile 16.20.2.5. Renal Profile 16.20.2.6. Thyroid Function Panel 16.20.2.7. Specialty Chemicals 16.20.3. Molecular Diagnostics 16.20.3.1. Polymerase Chain Reaction (PCR) 16.20.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 16.20.3.3. Hybridization (In-situ Hybridization & FISH) 16.20.3.4. DNA Sequencing & NGS 16.20.3.5. Microarray 16.20.3.6. Others 16.20.4. Microbiology 16.20.5. Hematology 16.20.6. Coagulation & Hemostasis 16.20.7. Urinalysis 16.20.8. Others 16.21. Mexico In-Vitro Diagnostics (IVD) Market Forecast, by Application 16.21.1. Food Processing 16.21.2. Dressing and Sauces 16.21.3. Ready Meals 16.21.4. Snacks & Savory Products 16.21.5. Infant Foods 16.21.6. Soups 16.21.7. Others 16.22. Rest of South America In-Vitro Diagnostics (IVD) Market Forecast, by Product 16.22.1. Reagents & Kits 16.22.2. Instruments 16.22.2.1. Fully-automated Instruments 16.22.2.2. Semi-automated Instruments 16.22.2.3. Others 16.22.3. Data Management Software 16.22.4. Services 16.23. Rest of South America In-Vitro Diagnostics (IVD) Market Forecast, by End User 16.23.1. Laboratories 16.23.1.1. Large/Reference Laboratories 16.23.1.2. Small & Medium-sized Laboratories 16.23.2. Hospitals 16.23.3. Academics 16.23.4. Point-Of-Care Testing 16.23.5. Patient Self-Testing 16.23.6. Others 16.24. Rest of South America In-Vitro Diagnostics (IVD) Market Forecast, by Technology 16.24.1. Immunochemistry 16.24.1.1. Enzyme-Linked Immunosorbent Assay (ELISA) 16.24.1.2. Radioimmunoassays (RIA) 16.24.1.3. Rapid Tests 16.24.1.4. Western Blot 16.24.1.5. ELISPOT 16.24.2. Clinical chemistry 16.24.2.1. Basic Metabolic Panel 16.24.2.2. Electrolyte Panel 16.24.2.3. Liver Panel 16.24.2.4. Lipid Profile 16.24.2.5. Renal Profile 16.24.2.6. Thyroid Function Panel 16.24.2.7. Specialty Chemicals 16.24.3. Molecular Diagnostics 16.24.3.1. Polymerase Chain Reaction (PCR) 16.24.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT) 16.24.3.3. Hybridization (In-situ Hybridization & FISH) 16.24.3.4. DNA Sequencing & NGS 16.24.3.5. Microarray 16.24.3.6. Others 16.24.4. Microbiology 16.24.5. Hematology 16.24.6. Coagulation & Hemostasis 16.24.7. Urinalysis 16.24.8. Others 16.25. Rest of South America In-Vitro Diagnostics (IVD) Market Forecast, by Application 16.25.1. Food Processing 16.25.2. Dressing and Sauces 16.25.3. Ready Meals 16.25.4. Snacks & Savory Products 16.25.5. Infant Foods 16.25.6. Soups 16.25.7. Others 16.26. South America In-Vitro Diagnostics (IVD) Market Attractiveness Analysis 16.26.1. By Product 16.26.2. By End User 16.26.3. By Technology 16.26.4. By Application 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Danaher Corporation 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Manufacturing Footprint 17.3.2. Carlyle Investment Management L.L.C. 17.3.3. Siemens AG 17.3.4. Becton, Dickinson, and Company 17.3.5. Thermo Fisher Scientific Inc. 17.3.6. F. Hoffmann-La Roche Ltd 17.3.7. BioMérieux SA 17.3.8. Abbott 17.3.9. Johnson & Johnson 17.3.10. Roche Diagnostics 17.3.11. Bio-Rad Laboratories 17.3.12. Sysmex Corporation 17.3.13. BioMérieux 17.3.14. DiaSorin 17.3.15. Ortho Clinical Diagnostics 17.3.16. Agilent Technologies 17.3.17. QIAGEN 18. Primary Key Insights

About This Report

Report ID362
Published DateDec 2017
Contact Us
Call Now